[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"biological-aging\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:biological-aging":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,42,70,99],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100640688","clinical-trial-evaluating-the-impact-of-a-dietary-supplement-containing-humic-and-fulvic-acid-on-epigenetic-markers-of-biological-age-detoxification-inflammation-and-oxidative-stress-100640688",false,"NCT07579845","Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress","Inclusion Criteria:\n\n1. Adult females or males age ≥ 40 years\n2. Ability to read and speak English\n\nExclusion Criteria:\n\n1. Current use of a dietary supplement containing fulvic or humic acid\n2. Current use of other binder dietary supplements, including activated charcoal, modified citrus pectin, bentonite clay, or chlorella\n3. Known allergies to any ingredients in the product\n4. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks\n5. Current diagnosis of a chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol\n6. Participants unable to provide consent",true,"ALL","40 Years",{"count":19,"type":20},60,"ESTIMATED","INTERVENTIONAL",[23],"NA","The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.",[26,27,28],"Detoxification","Inflammation","Biological Aging","RECRUITING","2026-05-27",{"date":32,"type":33},"2026-05-29","ACTUAL",{"date":35,"type":33},"2026-05-05",{"date":37,"type":20},"2026-09",{"name":39,"class":40},"OvationLab","NETWORK",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":15,"sex":16,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":54,"conditions":55,"keywords":56,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":4},"100541702","translational-initiative-to-map-epigenetics-in-sleep-100541702","NCT06333301","Translational Initiative to Map Epigenetics in Sleep","TIME-ZZZ","Inclusion Criteria:\n\n* Has taken an INDEX test within the last 3 months\n* Has registered at least 1 INDEX kit via the Elysium Health website\n* Able and willing to provide digital consent to the RSCF, and the TIME-ZZZ Research Subject Consent Form\n\nExclusion Criteria:\n\n* Consent to participate not given","18 Years","80 Years",{"count":52,"type":20},10000,"OBSERVATIONAL","The primary aim of TIME-ZZZ is to explore the relationship between chronotype, incidence of depression and biological age, and whether individuals working \"out-of-phase\" with their chronotype are more likely to exhibit signs of depression and accelerated biological aging.",[28],[57,58],"Sleep","Chronotype","NOT_YET_RECRUITING","2024-03-26",{"date":62,"type":33},"2024-03-27",{"date":64,"type":20},"2024-04",{"date":66,"type":20},"2034-04",{"name":68,"class":69},"Elysium Health","INDUSTRY",{"id":71,"slug":72,"hasResults":11,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":76,"eligibilityCriteria":77,"healthyVolunteers":15,"sex":16,"minAge":78,"maxAge":4,"enrollmentInfo":79,"targetDuration":81,"studyType":53,"phases":4,"briefSummary":82,"conditions":83,"keywords":84,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":41},"100379704","the-inspire-bio-resource-research-platform-for-healthy-aging-inspire-platform-100379704","NCT04224038","The Inspire Bio-resource Research Platform for Healthy Aging INSPIRE Platform","The Inspire Bio-resource Research Platform for Healthy Aging","INSPIRE","Inclusion Criteria:\n\n* Aged 30 years-old or over;\n* Both sexes\n* Affiliated to a social security scheme\n\nExclusion Criteria:\n\n* severe disease compromising life expectancy at 5 years;\n* Deprived of their liberty by administrative or judicial decision, or under guardianship","30 Years",{"count":80,"type":20},1000,"10 Years","Since aging is a systemic (not organ-specific) phenomenon, the main objective of Inspire Bio-resource Research Platform for Healthy Aging is to build a comprehensive research platform gathering biological, clinical (including imaging) and digital resources that will be explored to identify robust (set of) markers of aging, age-related diseases and IC evolution. The Inspire Platform will gather data and biospecimens from subjects of different ages (from 30 years or over - no upper limit for age) and functional capacity levels (from robust to frail to disabled) over 10 years.",[28],[85,86,75,87,88],"Geroscience","biological aging and identifying targetable biomarkers","Aged 30 years-old or over","age-related chronic diseases","2023-11-20",{"date":91,"type":33},"2023-11-21",{"date":93,"type":33},"2019-10-16",{"date":95,"type":20},"2033-10-31",{"name":97,"class":98},"University Hospital, Toulouse","OTHER",{"id":100,"slug":101,"hasResults":11,"nctId":102,"briefTitle":103,"officialTitle":103,"acronym":104,"eligibilityCriteria":105,"healthyVolunteers":15,"sex":16,"minAge":49,"maxAge":4,"enrollmentInfo":106,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":108,"conditions":109,"keywords":4,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":113,"completionDateStruct":114,"leadSponsor":116,"locationsCount":4},"100497692","the-translational-initiative-to-map-epigenetics-in-aging-time-a-100497692","NCT05760547","The Translational Initiative to Map Epigenetics in Aging (TIME-A)","TIME-A","Inclusion Criteria:\n\n* All adults aged 18 and above\n* Have registered at least one Index kit via the Elysium Health website\n* Able and willing to provide digital consent to the Research Consent Form, and the TIME-A Research Subject Consent Form\n\nExclusion Criteria:\n\n* Consent to participate not given",{"count":107,"type":20},25000,"The Translational Initiative to Map Epigenetics in Aging (TIME-A) study aims to advance our understanding of the connections between epigenetics, lifestyle, demographics, and health and aging.",[28],"2023-02-27",{"date":112,"type":33},"2023-03-08",{"date":112,"type":20},{"date":115,"type":20},"2033-03-31",{"name":68,"class":69}]